Aug 2026· Journal of Clinical Endocrinology and Metabolism· 0 citations
Medicine
TL;DR
Findings support a role for RAS/MAPK pathway dysregulation in brain development and highlight the clinical value of MRI in selected patients with NS.
Abstract
Context
Neuroradiological findings in Noonan syndrome (NS) remain insufficiently characterized.
Objective
To characterize neuroimaging abnormalities in children with genetically confirmed NS and evaluate their associations with clinical phenotype.
DESIGN, SETTING, AND
Participants
In this multicenter retrospective study, brain MRI scans and longitudinal clinical and genetic data were reviewed from children with genetically confirmed NS evaluated between 2008 and 2023 at seven pediatric endocrinology centers.
MAIN OUTCOME MEASURES
Prevalence and spectrum of neuroimaging abnormalities and their associations with genotype and clinical features.
Results
The cohort included 130 individuals with NS (71 males; mean age at MRI, 9.7 years), most carrying PTPN11 variants (69.2%). Structural brain abnormalities were identified in 84.7% and included midbrain-hindbrain malformations (69.2%), callosal anomalies (52.3%), cortical malformations (50%), white matter abnormalities (48.4%), and cranio-cervical junction anomalies (40%). Brain tumors and Chiari I malformation were present in 12.3% and 10.7%, respectively. Seizures were associated with cortical tumors (p = 0.02) and callosal anomalies (p = 0.03), whereas developmental delay was associated with callosal anomalies (p = 0.02) and microcephaly (p < 0.01). Follow-up MRI, available in 41 patients over a mean duration of 6.3 years, showed interval changes in 48.7%, including tumor progression, progressive tonsillar descent, odontoid retroversion, and newly detected lesions.
Conclusions
In this selected cohort of children with NS who underwent brain MRI as part of routine clinical care, structural brain abnormalities were frequent and were associated with neurological manifestations. These findings support a role for RAS/MAPK pathway dysregulation in brain development and highlight the clinical value of MRI in selected patients with NS.
This comprehensive characterization of brain MRI abnormalities in SCN2A disease revealed distinct imaging patterns across phenotypic subgroups that highlight the importance of early seizure control, guide counselling of patients and families, and inform MRI interpretation and biomarker research for future clinical tria...
Daniel Bamborschke, Z. Bendella, Meagan Allen et al.· Neurology· 0 citations
“hemiconvulsion-hemiplegia-epilepsy syndrome” is identified as a distinct feature and potential prognostic indicator for middle domain variants in DNM1L variants, which are predominantly missense, with the middle domain as a hotspot.
Han Xu, Chao-Long Xu, Ying Zou et al.· Frontiers in Neurology· 0 citations
BACKGROUND
The traditional distinction between syndromic and nonsyndromic craniosynostosis has guided clinical management, but recent genomic advances suggest these categories represent a continuous spectrum rather than discrete entities. Data on genetic etiologies and long-term neurodevelopmental outcomes in Asian pop...
Sunyoung Joo, Jeon-Woong Kang, Si Won Yang et al.· The Journal of craniofacial...· 0 citations
In this large clinical cohort, patients diagnosed with Korsakoff syndrome had a high burden of vascular comorbidities, frequent under-recognition of Wernicke encephalopathy, and substantial mortality, highlighting the need for earlier recognition and more standardized diagnostic evaluation of Korsakoff syndrome.
I. Coffi, Emmanuel Lecœur, K. Zarca et al.· JAMA Neurology· 1 citation
The cohort highlights novel findings, including the co-occurrence of AD LZTR1-NS with 22q11.2 deletion and two patients with AR NS with features suggestive of schwannomatosis, which expand the clinical spectrum of LZTR1-NS and have important implications for diagnosis, surveillance, and genetic counseling.
H. Jaouadi, Şakir Hicazi, Carolyn R. Raski et al.· American Journal of Medical...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.